Insulin-like Growth Factor 1 Promotes Recovery of Osteoblasts Following Gentamicin-induced Cytotoxicity

Read full text Summarise with VIRAT
Authors: Koki Okuyama, Soichiro Kimura, Tetsuji Aoyagi, Tetsuo Yamaguchi, Tsuji, Kentaro, Kazuhiro Tateda, Hiroshi Takahashi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: Fracture-related infections and implant-associated infections are major post-operative challenges encountered by orthopedic surgeons in their clinical practice. The occurrence of biofilm-forming bacteria on surgical implants is a serious problem that needs to be addressed post-surgically. Continuous local antibiotic perfusion (CLAP) using gentamicin (GM) for bone and soft tissue infections has been reported. This study aimed to elucidate the role of insulin-like growth factor 1 (IGF-1) in reducing the cytotoxicity associated with GM use in CLAP. In addition, we sought to assess the effectiveness of IGF-1 in facilitating the recovery of osteoblasts following CLAP treatment. Methods: Osteoblasts were treated with 1,000, 2,500, or 5,000 μg/mL GM, and the changes in cell number; alkaline phosphatase (ALP) activity; and gene expression levels of collagen type 1, ALP, and RUNX2 were determined. These drug concentrations were used to simulate the concentrations used in clinical practice. After the 10-day GM treatment, the cells were treated with or without IGF-1, and the changes in cell number; ALP activity; and gene expression levels of collagen type 1, ALP, and RUNX2 were determined. Results: GM treatment decreased the cell number, altered cell morphology, decreased ALP activity, and affected the expression of osteogenesis-related genes. Subsequent treatment with IGF-1 attenuated the GM-induced effects in the osteoblasts and partially recovered the cell number, morphology, ALP activity, and the expression of osteogenesis-related genes in GM-damaged cells. Conclusions: IGF-1 administration promoted the recovery of osteoblasts and attenuated GM-induced toxicity in osteoblasts.

Fields of Study & Subjects

Orthopedic Infections and Treatments Bone Tissue Engineering Materials Bone Metabolism and Diseases

Publication details

Journal / source
Institutional Repositories DataBase (IRDB)
Volume
12
Issue
1
Pages
9–18
Publication date
1 March 2026
Language
EN